• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合并肺纤维化和肺气肿的肺动脉高压相关血管病变的组织学分析:与单纯特发性肺纤维化或肺气肿的比较

Histological analysis of vasculopathy associated with pulmonary hypertension in combined pulmonary fibrosis and emphysema: comparison with idiopathic pulmonary fibrosis or emphysema alone.

作者信息

Awano Nobuyasu, Inomata Minoru, Ikushima Soichiro, Yamada Daisuke, Hotta Masatoshi, Tsukuda Shunji, Kumasaka Toshio, Takemura Tamiko, Eishi Yoshinobu

机构信息

Department of Human Pathology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan.

Department of Respiratory Medicine, Japanese Red Cross Medical Centre, Tokyo, Japan.

出版信息

Histopathology. 2017 May;70(6):896-905. doi: 10.1111/his.13153. Epub 2017 Feb 8.

DOI:10.1111/his.13153
PMID:27992963
Abstract

AIMS

To evaluate pulmonary vasculopathy in an autopsy series of patients with combined pulmonary fibrosis and emphysema (CPFE), and compare these findings with those of patients with idiopathic pulmonary fibrosis (IPF) alone and emphysema alone.

METHODS AND RESULTS

We retrospectively analysed the clinical, radiological and pathological features of 26 patients with CPFE, 11 with IPF, and 23 with emphysema. We evaluated pulmonary vascular, venous-venular and arteriolar tissue changes in the fibrotic, emphysematous and relatively unaffected (preserved) areas by using the Heath-Edwards scoring system. We found moderate-to-severe vasculopathy in the CPFE group, but no significant differences in the fibrotic and emphysematous areas among the three groups. However, in the preserved area, the grading was significantly different among the three groups (P < 0.001), and vasculopathy in the CPFE group was the most severe. Although venous-venular and arteriolar changes in almost all fibrotic and emphysematous areas in the three groups showed no significant differences, there were significant differences in venous-venular (P = 0.004) and arteriolar (P < 0.001) changes in the preserved area among the three groups, which were most prevalent in the CPFE group. In the CPFE group, venous-venular changes and vasculopathy by Heath-Edwards grading were highest in the fibrotic area and lowest in the preserved area.

CONCLUSIONS

These results imply that pulmonary vasculopathy in patients with CPFE could occur in the whole lung tissue. This may explain the tendency for it to lead to the development of pulmonary hypertension in CPFE cases.

摘要

目的

评估合并肺纤维化和肺气肿(CPFE)患者尸检系列中的肺血管病变,并将这些结果与单纯特发性肺纤维化(IPF)患者和单纯肺气肿患者的结果进行比较。

方法与结果

我们回顾性分析了26例CPFE患者、11例IPF患者和23例肺气肿患者的临床、放射学和病理学特征。我们使用希思-爱德华兹评分系统评估纤维化、肺气肿和相对未受影响(保留)区域的肺血管、静脉-小静脉和小动脉组织变化。我们发现CPFE组存在中度至重度血管病变,但三组之间纤维化和肺气肿区域无显著差异。然而,在保留区域,三组之间的分级有显著差异(P < 0.001),且CPFE组的血管病变最严重。尽管三组几乎所有纤维化和肺气肿区域的静脉-小静脉和小动脉变化均无显著差异,但三组保留区域的静脉-小静脉(P = 0.004)和小动脉(P < 0.001)变化存在显著差异,CPFE组最为普遍。在CPFE组中,静脉-小静脉变化和希思-爱德华兹分级的血管病变在纤维化区域最高,在保留区域最低。

结论

这些结果表明CPFE患者的肺血管病变可能发生在整个肺组织中。这可能解释了CPFE病例中其导致肺动脉高压发展的倾向。

相似文献

1
Histological analysis of vasculopathy associated with pulmonary hypertension in combined pulmonary fibrosis and emphysema: comparison with idiopathic pulmonary fibrosis or emphysema alone.合并肺纤维化和肺气肿的肺动脉高压相关血管病变的组织学分析:与单纯特发性肺纤维化或肺气肿的比较
Histopathology. 2017 May;70(6):896-905. doi: 10.1111/his.13153. Epub 2017 Feb 8.
2
Idiopathic pulmonary fibrosis with emphysema: evidence of synergy among emphysema and idiopathic pulmonary fibrosis in smokers.特发性肺纤维化合并肺气肿:吸烟者肺气肿与特发性肺纤维化协同作用的证据
Respir Care. 2015 Feb;60(2):259-68. doi: 10.4187/respcare.03389. Epub 2014 Nov 11.
3
An autopsy study of combined pulmonary fibrosis and emphysema: correlations among clinical, radiological, and pathological features.特发性肺纤维化合并肺气肿的尸检研究:临床、影像学和病理学特征的相关性。
BMC Pulm Med. 2014 Jun 28;14:104. doi: 10.1186/1471-2466-14-104.
4
Surgical Outcomes of Lung Cancer Patients with Combined Pulmonary Fibrosis and Emphysema and Those with Idiopathic Pulmonary Fibrosis without Emphysema.合并肺纤维化和肺气肿的肺癌患者与无肺气肿的特发性肺纤维化肺癌患者的手术结果。
Ann Thorac Cardiovasc Surg. 2016 Aug 23;22(4):216-23. doi: 10.5761/atcs.oa.15-00315. Epub 2016 Apr 5.
5
Combined pulmonary fibrosis and emphysema: a retrospective analysis of clinical characteristics, treatment and prognosis.合并性肺纤维化和肺气肿:临床特征、治疗及预后的回顾性分析
BMC Pulm Med. 2016 Nov 3;16(1):137. doi: 10.1186/s12890-016-0300-7.
6
Comparison of clinical characteristics and prognostic factors of combined pulmonary fibrosis and emphysema versus idiopathic pulmonary fibrosis alone.合并肺纤维化和肺气肿与单纯特发性肺纤维化的临床特征及预后因素比较。
Respirology. 2014 Feb;19(2):239-245. doi: 10.1111/resp.12207. Epub 2013 Nov 25.
7
[A comparison of clinical features between patients with idiopathic pulmonary fibrosis combined with emphysema and without emphysema].特发性肺纤维化合并肺气肿与未合并肺气肿患者的临床特征比较
Zhonghua Jie He He Hu Xi Za Zhi. 2013 Mar;36(3):173-6.
8
Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis.特发性肺纤维化合并肺气肿可延缓肺活量的下降。
Respir Med. 2009 Aug;103(8):1209-15. doi: 10.1016/j.rmed.2009.02.001. Epub 2009 Feb 28.
9
Morphological disease progression of combined pulmonary fibrosis and emphysema: comparison with emphysema alone and pulmonary fibrosis alone.合并性肺纤维化和肺气肿的形态学疾病进展:与单纯肺气肿及单纯肺纤维化的比较
J Comput Assist Tomogr. 2015 Mar-Apr;39(2):153-9. doi: 10.1097/RCT.0000000000000184.
10
Adenosine and hyaluronan promote lung fibrosis and pulmonary hypertension in combined pulmonary fibrosis and emphysema.腺苷和透明质酸促进合并肺纤维化和肺气肿的肺纤维化和肺动脉高压。
Dis Model Mech. 2019 May 15;12(5):dmm038711. doi: 10.1242/dmm.038711.

引用本文的文献

1
An increased risk of pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema: a meta-analysis.特发性肺纤维化合并肺气肿患者发生肺动脉高压的风险增加:一项荟萃分析。
BMC Pulm Med. 2023 Jun 21;23(1):221. doi: 10.1186/s12890-023-02425-4.
2
Combined Pulmonary Fibrosis and Emphysema: When Scylla and Charybdis Ally.肺纤维化合并肺气肿:当斯库拉和卡律布狄斯结盟。
Cells. 2023 Apr 28;12(9):1278. doi: 10.3390/cells12091278.
3
Use of machine learning models to predict prognosis of combined pulmonary fibrosis and emphysema in a Chinese population.
利用机器学习模型预测中国人群合并性肺纤维化和肺气肿的预后。
BMC Pulm Med. 2022 Aug 29;22(1):327. doi: 10.1186/s12890-022-02124-6.
4
Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement.特发性肺纤维化合并肺气肿综合征:美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会联合官方声明。
Am J Respir Crit Care Med. 2022 Aug 15;206(4):e7-e41. doi: 10.1164/rccm.202206-1041ST.
5
Combined Pulmonary Fibrosis Emphysema: Role of Cigarette Smoking and Pulmonary Hypertension in a Rural Cohort.合并性肺纤维化肺气肿:农村队列中吸烟和肺动脉高压的作用。
Int J Chron Obstruct Pulmon Dis. 2021 Jun 21;16:1873-1885. doi: 10.2147/COPD.S307192. eCollection 2021.
6
Oral 15-Hydroxyeicosatetraenoic Acid Induces Pulmonary Hypertension in Mice by Triggering T Cell-Dependent Endothelial Cell Apoptosis.15-羟基二十碳四烯酸通过触发 T 细胞依赖性内皮细胞凋亡诱导小鼠肺动脉高压。
Hypertension. 2020 Sep;76(3):985-996. doi: 10.1161/HYPERTENSIONAHA.120.14697. Epub 2020 Jul 27.
7
Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation.肺移植术治疗间质性肺疾病患者的肺血管病变。
BMJ Open Respir Res. 2020 Jul;7(1). doi: 10.1136/bmjresp-2019-000532.
8
Inflammatory signature in lung tissues in patients with combined pulmonary fibrosis and emphysema.肺纤维化合并肺气肿患者肺组织中的炎症特征。
Biomarkers. 2019 May;24(3):232-239. doi: 10.1080/1354750X.2018.1542458. Epub 2018 Nov 19.
9
Emphysema formation in a never-smoker with scleroderma-related interstitial pneumonia.硬皮病相关间质性肺炎的非吸烟者发生肺气肿
Respir Med Case Rep. 2018 Sep 13;25:211-212. doi: 10.1016/j.rmcr.2018.09.009. eCollection 2018.
10
Matrix remodeling in chronic lung diseases.慢性肺部疾病中的基质重构。
Matrix Biol. 2018 Nov;73:52-63. doi: 10.1016/j.matbio.2018.03.012. Epub 2018 Mar 17.